title: Structures of the E46K mutant-type α-synuclein protein and impact of E46K mutation on the structures of the wild-type α-synuclein protein.
abstract: The E46K genetic missense mutation of the wild-type α-synuclein protein was recently identified in a family of Spanish origin with hereditary Parkinson's disease. Detailed understanding of the structures of the monomeric E46K mutant-type α-synuclein protein as well as the impact of the E46K missense mutation on the conformations and free energy landscapes of the wild-type α-synuclein are required for gaining insights into the pathogenic mechanism of Parkinson's disease. In this study, we use extensive parallel tempering molecular dynamics simulations along with thermodynamic calculations to assess the secondary and tertiary structural properties as well as the conformational preferences of the monomeric wild-type and E46K mutant-type α-synuclein proteins in an aqueous solution environment. We also present the residual secondary structure component conversion stabilities with dynamics using a theoretical strategy, which we most recently developed. To the best of our knowledge, this study presents the first detailed comparison of the structural and thermodynamic properties of the wild-type and E46K mutant-type α-synuclein proteins in an aqueous solution environment at the atomic level with dynamics. We find that the E46K mutation results not only in local but also in long-range changes in the structural properties of the wild-type α-synuclein protein. The mutation site shows a significant decrease in helical content as well as a large increase in β-sheet structure formation upon E46K mutation. In addition, the β-sheet content of the C-terminal region increases significantly in the E46K mutant-type αS in comparison to the wild-type αS. Our theoretical strategy developed to assess the thermodynamic preference of secondary structure transitions indicates that this shift in secondary structure is the result of a decrease in the thermodynamic preference of turn to helix conversions while the coil to β-sheet preference increases for these residues. Long-range intramolecular protein interactions of the C-terminal with the N-terminal and NAC regions increase upon E46K mutation, resulting in more compact structures for the E46K mutant-type rather than wild-type αS. However, the E46K mutant-type αS structures are less stable than the wild-type αS. Overall, our results show that the E46K mutant-type αS has a higher propensity to aggregate than the wild-type αS and that the N-terminal and C-terminal regions are reactive toward fibrillization and aggregation upon E46K mutation and we explain the associated reasons based on the structural properties herein. Small molecules or drugs that can block the specific residues forming abundant β-sheet structure, which we report here, might help to reduce the reactivity of these intrinsically disordered fibrillogenic proteins toward aggregation and their toxicity.
authors: Department of Chemistry, The University of Texas at San Antonio, San Antonio, TX 78249, USA.
authors: Olivia
authors: O
authors: Wise-Scira
authors: Aquila
authors: A
authors: Dunn
authors: Ahmet K
authors: AK
authors: Aloglu
authors: Isin T
authors: IT
authors: Sakallioglu
authors: Orkid
authors: O
authors: Coskuner
mesh_terms: D006801:Humans; D050505:Mutant Proteins / Q000737:chemistry* / Q000235:genetics*; D020125:Mutation, Missense / Q000235:genetics*; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D051844:alpha-Synuclein / Q000737:chemistry* / Q000235:genetics*
chemical_list: D050505:Mutant Proteins; D051844:alpha-Synuclein
references: Neurotoxicology. 2002 Oct;23(4-5):553-67
references: 12428728
references: Nature. 1997 Aug 28;388(6645):839-40
references: 9278044
references: Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5645-50
references: 19293380
references: FEBS Lett. 2004 Oct 22;576(3):363-8
references: 15498564
references: J Chem Phys. 2005 Oct 15;123(15):154105
references: 16252940
references: J Biol Chem. 2009 Mar 13;284(11):7177-89
references: 19126542
references: Neurobiol Dis. 2011 Sep;43(3):715-24
references: 21684335
references: Biopolymers. 1983 Dec;22(12):2577-637
references: 6667333
references: Biochemistry. 2001 Sep 25;40(38):11604-13
references: 11560511
references: J Neurosci. 1988 Aug;8(8):2804-15
references: 3411354
references: J Biol Inorg Chem. 2012 Aug;17(6):927-38
references: 22674434
references: J Biol Chem. 2010 Sep 3;285(36):28261-74
references: 20592036
references: Science. 1997 Jun 27;276(5321):2045-7
references: 9197268
references: Proteins. 2004 May 1;55(2):383-94
references: 15048829
references: Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9
references: 21325059
references: Phys Chem Chem Phys. 2008 Apr 21;10(15):2073-7
references: 18688361
references: Science. 2003 Oct 31;302(5646):841
references: 14593171
references: Proteins. 2000 Jun 1;39(4):309-16
references: 10813813
references: J Chem Phys. 2011 Nov 28;135(20):205101
references: 22128957
references: Biochem Biophys Res Commun. 2009 Sep 18;387(2):305-9
references: 19580781
references: PLoS One. 2008 Apr 02;3(4):e1867
references: 18382657
references: J Biol Chem. 2005 Mar 4;280(9):7800-7
references: 15632170
references: J Biol Chem. 2001 Dec 7;276(49):45996-6003
references: 11590151
references: J Biol Chem. 2003 May 9;278(19):16873-7
references: 12621030
references: Biochem Biophys Res Commun. 2007 Apr 6;355(2):398-403
references: 17300751
references: Nat Genet. 1998 Feb;18(2):106-8
references: 9462735
references: Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8637-42
references: 18550842
references: J Neural Transm (Vienna). 2000;107(1):31-40
references: 10809401
references: Biochemistry. 2007 Jun 19;46(24):7107-18
references: 17530780
references: Science. 1996 Nov 15;274(5290):1197-9
references: 8895469
references: Nat Rev Neurosci. 2001 Jul;2(7):492-501
references: 11433374
references: Neuron. 2003 Oct 30;40(3):453-6
references: 14642269
references: Ann Neurol. 2004 Feb;55(2):164-73
references: 14755719
references: ACS Chem Neurosci. 2013 Feb 20;4(2):310-20
references: 23421682
references: Chembiochem. 2009 Jan 5;10(1):176-83
references: 19067456
references: J Mol Biol. 2009 May 22;388(5):1022-32
references: 19345692
references: J Biol Chem. 2000 Nov 3;275(44):34328-34
references: 10915790
references: J Alzheimers Dis. 2012;32(1):197-215
references: 22785403
references: J Mol Biol. 2001 Apr 6;307(4):1061-73
references: 11286556
references: Proteins. 2006 Nov 15;65(3):712-25
references: 16981200
references: Neurotoxicology. 2011 Dec;32(6):857-63
references: 21658409
references: Angew Chem Int Ed Engl. 2010 May 3;49(20):3469-72
references: 20544898
references: J Biol Chem. 1998 Apr 17;273(16):9443-9
references: 9545270
references: J Biol Chem. 2005 Sep 2;280(35):30649-52
references: 16020550
references: Trends Neurosci. 1998 Jun;21(6):249-54
references: 9641537
references: Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1430-5
references: 15671169
references: Acc Chem Res. 2000 Dec;33(12):889-97
references: 11123888
references: Biochemistry. 2003 Jan 28;42(3):672-8
references: 12534279